Alan Steinberg, MD
Geriatric Psychiatry · Centereach, NYNPI 1225022072
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $7,147 of the $8,236 with a category attached, or 86.8%. Otsuka America Pharmaceutical, Inc. accounts for 92.1% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2019 at $5,610 and has fallen 99.6% since, to $24 in 2024. Among geriatric psychiatry clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 58 payments — averaging $142.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$8K
- Neurocrine Biosciences, Inc.$169
- Lundbeck LLC$164
- Acadia Pharmaceuticals Inc$82
- AbbVie$48
- Johnson & Johnson$37
- plus $148 from 7 others
What the payments were for
- Speaking & faculty fees$7,14787%
- Food & beverage$1,08913%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 22 | $7,587 |
| Neurocrine Biosciences, Inc. | 8 | $169 |
| Lundbeck LLC | 9 | $164 |
| Acadia Pharmaceuticals Inc | 6 | $82 |
| AbbVie | 3 | $48 |
| Johnson & Johnson | 2 | $37 |
| Strongbridge US Inc. | 2 | $27 |
| Shire North American Group Inc | 1 | $24 |
| Vanda Pharmaceuticals Inc. | 1 | $22 |
| Neuronetics, Inc. | 1 | $21 |
| Avanir Pharmaceuticals, Inc. | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Alfasigma USA, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- REXULTI$7,287
How this compares
$8,236 in reported general payments places this provider in the 90th percentile of 45 geriatric psychiatry providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clozapine | 108 | $6,488 |
| Clozapine OdtClozapine | 11 | $2,880 |
| Ziprasidone Hcl | 26 | $2,493 |
| Divalproex Sodium ErDivalproex Sodium | 11 | $1,010 |
| Haloperidol | 21 | $410 |
| Benztropine Mesylate | 31 | $371 |
| Buspirone Hcl | 17 | $322 |
| Quetiapine Fumarate | 26 | $213 |
| Duloxetine Hcl | 13 | $209 |
| Bupropion XlBupropion Hcl | 14 | $163 |
| AmantadineAmantadine Hcl | 15 | $136 |
| Aripiprazole | 12 | $131 |
| Lamotrigine | 15 | $128 |
| Paroxetine Hcl | 13 | $99 |
| Trazodone Hcl | 11 | $64 |
Paid to pharmacies, not to this prescriber.
Other geriatric psychiatry in Centereach
- Stephanie InfanteCentereach$3K
- Davangere DevanandBinghamton$137K
- Diane AnnalettBuffalo$12K
- Roberto EstradaNew York$8K
- Istvan BoksayNew York$8K
- Barry ReisbergNew York$5K
- Miguel Sanchez-AlmiraBrooklyn$5K
- Emily ClarkRochester$3K
- Karan KumarAmityville$3K
- Vilas PatilOswego$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.